|
1
|
Rivera C: Essentials of oral cancer. Int J
Clin Exp Pathol. 8:11884–11894. 2015.PubMed/NCBI
|
|
2
|
Weckx A, Riekert M, Grandoch A, Schick V,
Zöller JE and Kreppel M: Time to recurrence and patient survival in
recurrent oral squamous cell carcinoma. Oral Oncol. 94:8–13. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Omar E: Current concepts and future of
noninvasive procedures for diagnosing oral squamous cell
carcinoma-a systematic review. Head Face Med. 11:62015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Safi AF, Kauke M, Grandoch A, Nickenig HJ,
Zöller JE and Kreppel M: Analysis of clinicopathological risk
factors for locoregional recurrence of oral squamous cell
carcinoma-retrospective analysis of 517 patients. J
Craniomaxillofac Surg. 45:1749–1753. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Collado M and Serrano M: Senescence in
tumours: Evidence from mice and humans. Nat Rev Cancer. 10:51–57.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yadav RK, Chauhan AS, Zhuang L and Gan B:
FoxO transcription factors in cancer metabolism. Semin Cancer Biol.
50:65–76. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chae YC, Kim JY, Park JW, Kim KB, Oh H,
Lee KH and Seo SB: FOXO1 degradation via G9a-mediated methylation
promotes cell proliferation in colon cancer. Nucleic Acids Res.
47:1692–1705. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong T, Zhang Y, Chen Y, Liu P, An T,
Zhang J, Yang H, Zhu W and Yang X: FOXO1 inhibits the invasion and
metastasis of hepatocellular carcinoma by reversing ZEB2-induced
epithelial-mesenchymal transition. Oncotarget. 8:1703–1713. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Furuyama T, Kitayama K, Shimoda Y, Ogawa
M, Sone K, Yoshida-Araki K, Hisatsune H, Nishikawa S, Nakayama K,
Nakayama K, et al: Abnormal angiogenesis in Foxo1 (Fkhr)-deficient
mice. J Biol Chem. 279:34741–34749. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cancer Genome Atlas Research Network, .
The molecular taxonomy of primary prostate cancer. Cell.
163:1011–1025. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Trinh DL, Scott DW, Morin RD, Mendez-Lago
M, An J, Jones SJ, Mungall AJ, Zhao Y, Schein J, Steidl C, et al:
Analysis of FOXO1 mutations in diffuse large B-cell lymphoma.
Blood. 121:3666–3674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hornsveld M, Smits LMM, Meerlo M, van
Amersfoort M, Groot Koerkamp MJA, van Leenen D, Kloet DEA, Holstege
FCP, Derksen PWB, Burgering BMT and Dansen TB: FOXO transcription
factors both suppress and support breast cancer progression. Cancer
Res. 78:2356–2369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sanjana NE, Shalem O and Zhang F: Improved
vectors and genome-wide libraries for CRISPR screening. Nat
Methods. 11:783–784. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van der Meij EH and van der Waal I: Lack
of clinicopathologic correlation in the diagnosis of oral lichen
planus based on the presently available diagnostic criteria and
suggestions for modifications. J Oral Pathol Med. 32:507–512. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi W, Yang J, Li S, Shan X, Liu X, Hua H,
Zhao C, Feng Z, Cai Z, Zhang L and Zhou D: Potential involvement of
miR-375 in the premalignant progression of oral squamous cell
carcinoma mediated via transcription factor KLF5. Oncotarget.
6:40172–40185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee EJ, Kim J, Lee SA, Kim EJ, Chun YC,
Ryu MH and Yook JI: Characterization of newly established oral
cancer cell lines derived from six squamous cell carcinoma and two
mucoepidermoid carcinoma cells. Exp Mol Med. 37:379–390. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gene Ontology Consortium: The gene
ontology resource: Enriching a GOld mine. Nucleic Acids Res.
49(D1): D325–D334. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mi H, Muruganujan A, Ebert D, Huang X and
Thomas PD: PANTHER version 14: More genomes, a new PANTHER GO-slim
and improvements in enrichment analysis tools. Nucleic Acids Res.
47(D1): D419–D426. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Birkenkamp-Demtröder K, Hahn SA, Mansilla
F, Thorsen K, Maghnouj A, Christensen R, Øster B and Ørntoft TF:
Keratin23 (KRT23) knockdown decreases proliferation and affects the
DNA damage response of colon cancer cells. PLoS One. 8:e735932013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sequeira I and Watt FM: The role of
keratins in modulating carcinogenesis via communication with cells
of the immune system. Cell Stress. 3:136–138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu H, Wang K, Liu W and Hao Q: PTEN
overexpression improves cisplatin-resistance of human ovarian
cancer cells through upregulating KRT10 expression. Biochem Biophys
Res Commun. 444:141–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gkouveris I, Nikitakis N, Karanikou M,
Rassidakis G and Sklavounou A: Erk1/2 activation and modulation of
STAT3 signaling in oral cancer. Oncol Rep. 32:2175–2182. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saxena NK, Sharma D, Ding X, Lin S, Marra
F, Merlin D and Anania FA: Concomitant activation of the JAK/STAT,
PI3K/AKT, and ERK signaling is involved in leptin-mediated
promotion of invasion and migration of hepatocellular carcinoma
cells. Cancer Res. 67:2497–2507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ponugoti B, Xu F, Zhang C, Tian C, Pacios
S and Graves DT: FOXO1 promotes wound healing through the
up-regulation of TGF-β1 and prevention of oxidative stress. J Cell
Biol. 203:327–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kesarwala AH, Krishna MC and Mitchell JB:
Oxidative stress in oral diseases. Oral Dis. 22:9–18. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Olmos Y, Sánchez-Gómez FJ, Wild B,
García-Quintans N, Cabezudo S, Lamas S and Monsalve M: SirT1
regulation of antioxidant genes is dependent on the formation of a
FoxO3a/PGC-1α complex. Antioxid Redox Signal. 19:1507–1521. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Q, Sztukowska M, Ojo A, Scott DA,
Wang H and Lamont RJ: FOXO responses to Porphyromonas gingivalis in
epithelial cells. Cell Microbiol. 17:1605–1617. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Filomeni G, De Zio D and Cecconi F:
Oxidative stress and autophagy: The clash between damage and
metabolic needs. Cell Death Differ. 22:377–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y
and Li Y: Inflammation and tumor progression: Signaling pathways
and targeted intervention. Signal Transduct Target Ther. 6:2632021.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xie L, Ushmorov A, Leithäuser F, Guan H,
Steidl C, Färbinger J, Pelzer C, Vogel MJ, Maier HJ, Gascoyne RD,
et al: FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
Blood. 119:3503–3511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Duan X, Kong Z, Liu Y, Zeng Z, Li S, Wu W,
Ji W, Yang B, Zhao Z and Zeng G: β-Arrestin2 contributes to cell
viability and proliferation via the down-regulation of FOXO1 in
castration-resistant prostate cancer. J Cell Physiol.
230:2371–2381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin A, Yao J, Zhuang L, Wang D, Han J, Lam
EW and Gan B: The FoxO-BNIP3 axis exerts a unique regulation of
mTORC1 and cell survival under energy stress. Oncogene.
33:3183–3194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kode A, Mosialou I, Manavalan SJ, Rathinam
CV, Friedman RA, Teruya-Feldstein J, Bhagat G, Berman E and
Kousteni S: FoxO1-dependent induction of acute myeloid leukemia by
osteoblasts in mice. Leukemia. 30:1–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han GH, Chay DB, Nam S, Cho H, Chung JY
and Kim JH: Prognostic implications of forkhead box protein O1
(FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer. BMC
Cancer. 19:12022019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vasquez YM, Mazur EC, Li X, Kommagani R,
Jiang L, Chen R, Lanz RB, Kovanci E, Gibbons WE and DeMayo FJ:
FOXO1 is required for binding of PR on IRF4, novel transcriptional
regulator of endometrial stromal decidualization. Mol Endocrinol.
29:421–433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gao P, Zhang H, Dinavahi R, Li F, Xiang Y,
Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, et al:
HIF-dependent antitumorigenic effect of antioxidants in vivo.
Cancer Cell. 12:230–238. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sabharwal SS, Waypa GB, Marks JD and
Schumacker PT: Peroxiredoxin-5 targeted to the mitochondrial
intermembrane space attenuates hypoxia-induced reactive oxygen
species signalling. Biochem J. 456:337–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dwivedi R, Pandey R, Chandra S and
Mehrotra D: Dendritic cell-based immunotherapy: A potential player
in oral cancer therapeutics. Immunotherapy. 15:457–469. 2023.
View Article : Google Scholar : PubMed/NCBI
|
